Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Inventory (2016 - 2026)

Cryo Cell International's Inventory history spans 13 years, with the latest figure at $356991.0 for Q1 2026.

  • Quarterly results put Inventory at $356991.0 for Q1 2026, down 51.13% from a year ago — trailing twelve months through Feb 2026 was $356991.0 (down 51.13% YoY), and the annual figure for FY2025 was $408794.0, down 37.85%.
  • Inventory for Q1 2026 was $356991.0 at Cryo Cell International, down from $408794.0 in the prior quarter.
  • In the past five years, Inventory ranged from a high of $1.1 million in Q3 2023 to a low of $356991.0 in Q1 2026.
  • The 5-year median for Inventory is $755160.0 (2024), against an average of $756646.7.
  • The sharpest move saw Inventory increased 15.62% in 2023, then tumbled 51.13% in 2026.
  • Year by year, Inventory stood at $851230.0 in 2022, then fell by 9.67% to $768877.0 in 2023, then dropped by 14.46% to $657703.0 in 2024, then tumbled by 37.85% to $408794.0 in 2025, then decreased by 12.67% to $356991.0 in 2026.
  • According to Business Quant data, Inventory over the past three periods came in at $356991.0, $408794.0, and $655254.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.